ADVFN - Advanced Financial Network.
HOME» NASDAQ » S » SOMX Stock Price » SOMX Stock News

Somaxon Share News

 Somaxon Pharmaceuticals (mm) Stock Price
SOMX Stock Price
 Somaxon Pharmaceuticals (mm) Stock Chart
SOMX Stock Chart
 Somaxon Pharmaceuticals (mm) Stock News
SOMX Stock News
 Somaxon Pharmaceuticals (mm) Company Information
SOMX Company Information
 Somaxon Pharmaceuticals (mm) Stock Trades
SOMX Stock Trades

Somaxon Files Lawsuit Against Par Pharma Involving Generic Silenor

DOW JONES NEWSWIRES Somaxon Pharmaceuticals Inc. (SOMX) disclosed it filed a patent-infringement lawsuit against Par Pharmaceutical Inc. (PRX), following Par's request for approval to market generic versions of sleep aid Silenor in the U.S. The suit is Somaxon's latest against a generic applicant for Silenor, its first product on the market. In February, it filed a separate lawsuit against Par that involved a different patent also related to Silenor. It has also engaged in litigation with companies such as Mylan Inc. (MYL). Par couldn't immediately be reached for comment. Somaxon reported earlier this month its first-quarter loss widened sharply on higher costs, though it reported product sales, of which it had none a year earlier. Somaxon's shares closed down Friday at $2.35, while Par finished higher at $33.62. Neither was active after-hours. -By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; [email protected]

Stock News for Somaxon (SOMX)
No Recent News Available

Somaxon Pharmaceuticals and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations